短链脂肪酸丁酸抑制动脉粥样硬化形成及其分子机制

本研究通过观察丁酸对动脉粥样硬化斑块形成以及肠道组织结构和功能的影响,探讨丁酸防治动脉粥样硬化的效应及可能机制.选取8周龄雄性载脂蛋白E基因敲除(apolipoprotein E-knockout,ApoE-/-)小鼠,随机分成对照组(高脂高胆固醇饲料+饮水中给予200 mmol/L氯化钠,n = 10)和丁酸组(高脂...     

平台化学品短链支链脂肪酸和短链支链醇的微生物代谢工程

短链支链脂肪酸和短链支链醇均为重要的平台化学品,是合成多种高附加值产品的前体物质,市场需求巨大。目前两者的生产主要是利用基于石化原料的化学合成法。化学合成法存在着严重依赖化石燃料、反应效率低以及极易造成环境污染等缺点。微生物代谢工程的快速发展为这些平台化学品的生产提供了一条极具潜力的生物合成路线。利用微生物代谢工程技术构建生产这些平台化学品的微生物细胞工厂具有绿色清洁、可持续发展和经济效益好等独特优势。本文系统综述了近年来微生物代谢工程技术在短链支链脂肪酸和短链支链醇合成方面的研究进展,包括所涉及的宿主菌株、关键酶、代谢途径及其改造等,并探讨了未来的发展前景。     

短链脂肪酸调控骨代谢的作用及机制的研究进展

肠道菌群紊乱可导致宿主病理性骨质流失,其通过产生的代谢物从肠道扩散到体循环对骨代谢发挥重要的调控作用。短链脂肪酸（Short Chain Fatty Acids,SCFAs）是肠道细菌产生的代谢物家族中最受关注的代谢产物,近年来研究表明,SCFAs在骨代谢相关疾病的发生发展中具有重要调节作用。本文就其在骨骼系统中的作用、调节骨组织中细胞的机制及作为靶点防治骨代谢疾病骨质疏松的研究进行综述,并为此新兴且具有前景的研究领域在未来的基础研究和转化研究提供展望。     

短链脂肪酸在功能性便秘中作用的研究进展

功能性便秘是一种多因素引起的疾病,其发病机制尚不明确,目前认为主要与饮食习惯、遗传、运动和精神压力等有关,临床表现为排便次数减少、排便费力、粪便干结及腹部胀痛等,在儿童时期较为常见。该病虽然治疗效果良好,但停药后症状易反复,严重影响儿童的肠道功能和心理健康。短链脂肪酸是肠道菌群重要的代谢产物,越来越多的证据表明,其与肠道多种疾病的发生发展密切相关。本文从短链脂肪酸调节胃肠道动力、平衡肠道菌群和调节中枢神经系统等方面对功能性便秘作用的研究进展进行综述。

     

取代短链脂肪酸对秀丽隐杆线虫的抗氧化作用

短链脂肪酸(short chain fatty acids, SCFAs)是碳原子数为1～6的有机脂肪酸,不但可以作为生物体内能源物质,而且还具有抗炎、影响肠道菌群代谢和预防早发1型糖尿病等重要作用。然而,目前多数是对传统短链脂肪酸的生物学作用进行研究,对取代短链脂肪酸(short branched-chain fatty acids, SBCFAs)的相关研究甚少。本研究以秀丽隐杆线虫为模式动物,系统探究SBCFAs的抗氧化生物活性作用。采用胡桃醌氧化应激模型,在体内评价SBCFAs对秀丽隐杆线虫生存能力的影响,并通过体外抗氧化及H_2DCFDA荧光染色实验,进一步评价SBCFAs清除活性氧自由基(reactive oxygen species,ROS)的能力。本研究证实,在氧化应激研究中,传统脂肪酸不能延长秀丽隐杆线虫的存活时间,而2′-甲基取代短链脂肪酸(n=4-6)具有显著的抗氧化作用。体外抗氧化实验表明,2′-甲基取代短链脂肪酸(n=4-6)不具有体外直接清除ROS的能力,但是H_2DCFDA荧光染色实验显示2′-甲基丁酸能够显著降低线虫体内的ROS水平,表明2′-甲基丁酸通过降低体内ROS水平,从而增强秀丽隐杆线虫的抗氧化应激能力。本研究提示,传统短链脂肪酸不具有抗氧化作用;2′-甲基取代短链脂肪酸(n=4-6)能显著增强秀丽隐杆线虫的抗氧化能力;甲基取代位置和取代烷基长度对短支链脂肪酸的抗氧化作用至关重要,其作用机制需进一步研究。     

鸡肠道菌群和短链脂肪酸相互关系的研究进展

肠道是动物机体重要的消化和营养吸收器官。肠道菌群决定肠道健康,进而影响机体健康。近来关于肠道菌群的研究越来越多,且肠道菌群酵解底物产生的短链脂肪酸也备受人们关注。短链脂肪酸主要包括乙酸、丙酸、丁酸等及其盐类。在对肠道功效方面,短链脂肪酸发挥着重要作用,如氧化供能、维持水电解质平衡、调节免疫、抗病原微生物及抗炎、调节肠道菌群平衡、改善肠道功能等。因此,本文根据近年来国内外相关研究报道,综述了鸡肠道不同种类、含量的菌群对短链脂肪酸来源和吸收的影响;不同种类、含量和制剂形态的短链脂肪酸对肠道菌群影响的研究进展,为更好地了解鸡肠道菌群和短链脂肪酸的相互关系和提高禽类养殖水平提供理论指导。     

短链脂肪酸受体GPR43的研究进展

短链脂肪酸受体(G protein-coupled receptor 43,GPR43)属于G蛋白偶联受体(G protein-coupled receptors,GPCR)家族,因其与脂肪和糖代谢相关,在过去的10年中其研究日益受到重视。研究表明,GPR43不仅可以通过参与调节食欲和胃肠肽的分泌来调节脂肪的分解与形成,最终与代谢性疾病如肥胖、2型糖尿病和心血管病的密切相关;而且GPR43还参与调节人身体血脂浓度和炎症发生过程,甚至还与细胞的癌变密切相关。GPR43作为糖代谢、脂肪代谢的重要调节受体,已经成为一个重要的药物筛选靶点。针对GPR43受体的研究现状进行了总结并对今后的应用研究进行了展望。     

老年小鼠肠道短链脂肪酸含量和菌群特征关联性探究

随着社会经济的发展,我国人口老龄化日益严重,衰老这个永恒的问题又一次引起人们的关注.肠道菌群失衡是衰老发生发展的关键因素,而短链脂肪酸(short chain fatty acids,SCFAs)是介导菌群影响机体的主要方式之一.研究衰老、肠道菌群及SCFAs三者之间的关系,能够为临床通过干预肠道菌群影响SCFAs含量...     

运动、肠道菌群代谢物——短链脂肪酸与骨骼肌代谢调控

寄生于人体的肠道菌群是一个高度动态化和个体化的复杂生态系统,受遗传、环境、饮食、年龄和运动等因素的影响,并通过其产生的代谢物与机体众多组织器官产生广泛的应答效应。短链脂肪酸(short chain fatty acid, SCFA)主要是由位于盲肠和结肠内的菌群以膳食纤维为底物发酵产生,其被吸收进入肠系膜上下静脉,随后汇入门静脉至肝。部分短链脂肪酸被肝作为糖异生和脂质合成的底物,剩余的短链脂肪酸以游离脂肪酸的形式经肝静脉进入外周循环。研究发现,运动可使产生SCFA的肠道菌群组分的丰度提高和参与调控SCFA生成的相关基因表达增加,使肠道中短链脂肪酸含量增加。由短链脂肪酸刺激结肠内分泌细胞合成分泌的胰高血糖素样肽1(glucagon like peptide-1, GLP-1)可促使胰岛B细胞合成分泌胰岛素,进而调节骨骼肌的葡萄糖摄取与糖原合成。此外,短链脂肪酸通过提高骨骼肌胰岛素受体底物1(insulin receptor substrate 1,IRS1)基因转录起始位点附近的组蛋白乙酰化水平,增强骨骼肌的胰岛素敏感性。同时,短链脂肪酸通过激活腺苷酸活化蛋白质激酶(AMP-activated protein kinase, AMPK)促进骨骼肌的脂肪酸摄取、脂肪分解和线粒体生物发生,抑制脂肪合成。本文就肠道菌群代谢物——短链脂肪酸概述、运动对产生短链脂肪酸的肠道菌群的影响和运动介导肠道菌群代谢物——短链脂肪酸对骨骼肌代谢调控机制的最新研究进展进行综述,为骨骼肌运动适应的新机制研究提供理论依据。     

野牦牛和家牦牛粪便菌群与短链脂肪酸关系的研究

短链脂肪酸(SCFA)是反刍动物吸收饲草、饲料中营养物质的重要形式。肠道菌群能够降解食物生成SCFA并影响其比例。本文通过16S r DNA测序和气相色谱质谱联用仪,分别测定了野牦牛(Bos mutus)和家牦牛(Bos grunniens)粪便菌群组成及SCFA含量,通过比较分析两种牦牛肠道菌群与SCFA的关系,筛选出野牦牛肠道中与SCFA高浓度有正相关关系的菌群。结果显示,野牦牛粪便菌群主要有厚壁菌门(Firmicutes)(66. 47%)、拟杆菌门(Bacteroidetes)(26. 00%)和变形菌门(Proteobacteria)(3. 48%),主要的科有瘤胃球菌科(Ruminococcaceae)(55. 18%)、拟杆菌科(Bacteroidaceae)(8. 75%)和毛螺菌科(Lachnospiraceae)(7. 57%),家牦牛的菌群结构和组成与野牦牛相似。野牦牛粪便中SCFA以乙酸和丙酸为主,乙酸、丙酸、异丁酸、正丁酸和正戊酸的含量均显著高于家牦牛(P <0. 01)。Spearman相关分析显示,野牦牛粪便菌群中紫单胞菌科(Porphyromonadaceae)、拟杆菌科(Bacteroidaceae)、普雷沃氏菌科(Paraprevotellaceae)、理研菌科(Rikenellaceae)和韦荣球菌科(Erysipelotrichaceae)与SCFA具有较强相关性(r> 0. 4),而家牦牛仅有弱相关性(r <0. 3)。说明牦牛后肠道具有丰富的能够促进SCFA生成的益生菌群,进而提高食物的转化效率。     

乳酸杆菌、双歧杆菌代谢产物的气相色谱分析

用气相色谱分析乳酸杆菌、双歧杆菌提取物,结果表明乳酸杆菌提取物中乙酸的含量很高,双歧杆菌提取物挥发性脂肪酸种类较多,有乙酸、丙酸、异丁酸及丁酸等多种短链脂肪酸.分析结果表明短链脂肪酸很可能是乳酸杆菌、双歧杆菌提取物抑菌的主要活性成分.     

Absorption and metabolism of short‐chain fatty acids in ruminants

Short‐chain fatty acids (SCFA), viz. acetate, propionate and butyrate are quantitatively important substrates in ruminant energy metabolism. In the reviewed literature, 16–44% of ME intake was recovered as portal appearance of SCFA. This is considerably lower than expected when related to the estimated intra‐gastric flux of SCFA. The discrepancy is caused by portal drained viscera metabolism of arterially abundant metabolites e.g., acetate and the metabolism of acetate and butyrate to acetoacetate and D‐3‐hydroxybu‐tyrate in the absorptive epithelia. Even though considerable variations between experiments on acetate and propionate appearance are found, there seems to be a great deal of evidence that the proportion of gastroin‐testinally produced acetate and propionate absorbed to the portal blood is 50–75%. The portal recovery of butyrate has been found to be between 10 and 36% dependent on intraruminal infusion rate.

It is concluded that major parts of acetate and propionate are directly absorbed to the portal vein. The true absorption rate of acetate can only be estimated by taking the portal drained viscera metabolism of arterial actetate into account. Butyrate is generally found to have a low recovery in the portal vein, but the production of D‐3‐hydroxybutyrate seems to be underestimated in major parts of the literature. It is therefore necessary to measure portal appearance as well as portal drained viscera metabolism to assess the quantitative as well as the qualitative contribution of SCFA and SCFA metabolites to whole animal metabolism.     

具有新一代益生菌潜能的罗氏菌在各类疾病中调节作用的研究进展

肠道菌群与宿主之间存在着密不可分的互惠共生关系,菌群异常与疾病的发生发展密切相关。国内外研究发现了一种革兰阳性厌氧菌——罗氏菌（Roseburia）,它能产生对人体有益的短链脂肪酸（尤其是丁酸）。罗氏菌可调节宿主代谢、肠道屏障和肠道菌群组成,对机体有益,显示出良好的开发和应用前景,有望成为新一代的益生菌。然而,目前对罗氏菌的研究仍局限于其丰度和短链脂肪酸的产量上,并没有关注罗氏菌本身对人体健康的调节作用。本文就罗氏菌在人体各种疾病中的改善作用作一概述,以期为进一步研究和开发罗氏菌提供参考。

     

The absorption of calcium ions from the ovine reticulo-rumen

Net Ca²⁺ and Mg²⁺ absorption rates were measured in vivo from buffer solutions placed in the washed reticulo-rumen, isolated in situ in 30 conscious, trained sheep. An increase in concentration of short chain fatty acids (SCFA) in the buffer, over the range 0–50 mM, was shown to stimulate the net rates of absorption of Ca²⁺ and Mg²⁺ ions from the rumen. Similarly, the results of in vitro experiments, carried out with ovine rumen epithelium mounted in short-circuited Ussing chambers, showed that the absence of SCFA from the chamber fluid resulted in a reduction in J_net Ca²⁺ caused by reduced flux of Ca²⁺ ions in the mucosal to serosal direction (J_ms Ca²⁺). The addition of 1 mM acetazolamide, an inhibitor of carbonic anhydrase, to the ruminal buffer used in the in vivo experiments led to significant reductions in the net absorption rates of Ca²⁺and Mg²⁺ ions in the presence of SCFA (50 mmol l⁻¹) but not in the absence of SCFA. However, in the in vitro experiments, the addition of 60 μM ethoxyzolamide had no significant effect on J_net Ca²⁺. A reduction in pH of the intraruminal buffer in vivo from 6.8 to 5.4 led to significant increases in the net absorption rates of Ca²⁺and Mg²⁺ ions, an effect which was duplicated for Ca²⁺ in preliminary in vitro experiments in which the pH of the mucosal buffer was reduced from 7.4 to 5.4. This stimulatory effect was confined to J_ms Ca²⁺ and J_net Ca²⁺. Ussing chambers were also used to demonstrate that J_net Ca²⁺ was reduced by a high transmural potential difference (PD), caused by voltage clamping, independently of the mucosal K⁺ concentration. Both unidirectional Ca²⁺ fluxes consisted of a PD-dependent and a K⁺-insensitive PD-independent component. The latter may be represented by a Ca²⁺/2H⁺ antiporter. It is postulated that SCFA, and to a lesser extent H₂CO₃, can stimulate J_ms Ca²⁺ by activation of an apical Ca²⁺/2H⁺ antiporter through the provision of protons within the ruminal epithelial cell. A mild reduction in ruminal pH may also lead to a similar stimulation of this putative electroneutral exchange. Accepted: 26 July 2000     

男子橄榄球运动员肠道菌群特征和短链脂肪酸水平及其抗炎作用分析

观察男子橄榄球运动员所承受的强烈身体对抗及专项运动负荷对其肠道菌群结构特征与短链脂肪酸水平的影响,并观察其对机体炎症反应的可能影响。

本试验招募男子橄榄球运动员30人作为试验组,招募非体育专业的在校男大学生15人作为对照组。分别按测试计划采集受试者空腹静脉血,收集粪便样本。采用酶联免疫吸附法测定受试者血浆中白介素（IL）-1、IL-6、IL-10、C反应蛋白（CRP）的水平。采用16S rDNA V3−V4区测序法比较受试者肠道菌群组成和结构。采用气相色谱−质谱联用法（GC-MS）测定受试者粪便样本中短链脂肪酸（乙酸、丙酸、丁酸、戊酸）的含量。

（1）试验组对象血浆中CRP水平显著低于对照组（P＜0.01）,其余指标未见显著差异。（2）与对照组相比,试验组对象粪便样本中普通拟杆菌（Bacteroides vulgatus）、伶俐粪球菌（Coprococcus comes）和食葡糖罗斯拜瑞菌（Roseburia inulinivorans）丰度均显著高于对照组（均P＜0.05）。（3）与对照组相比,试验组对象肠道菌群Observed-species指数、Shannon指数均显著高于对照组（均P＜0.05）。（4）与对照组相比,试验组对象粪便样本中乙酸、丙酸、丁酸浓度均显著升高（均P＜0.05）。

橄榄球运动员血浆中促炎因子CRP水平显著下降,提示其专项运动训练可发挥抗炎效应。橄榄球运动员所承受的专项运动负荷,可能会对其肠道微生物体系产生较大影响,其中菌群的改变可促使肠道中短链脂肪酸的生成增加。

     

A quantitative headspace–solid-phase microextraction–gas chromatography–flame ionization detector method to analyze short chain free fatty acids in rat feces

This study sought to develop and validate a quantitative method to analyze short chain free fatty acids (SCFAs) in rat feces by solid-phase microextraction and gas chromatography (SPME–GC) using the salt mixture ammonium sulfate and sodium dihydrogen phosphate as salting out agent. Conditioning and extraction time, linearity, limits of detection and quantification, repeatability, and recovery were evaluated. The proposed method allows quantification with improved sensitivity as compared with other methods exploiting SPME–GC. The method has been applied to analyze rat fecal samples, quantifying acetic, propionic, isobutyric, butyric, isopentanoic, pentanoic, and hexanoic acids.     

短链脂肪酸对肠黏膜屏障的影响

肠黏膜屏障具有将致病性抗原等肠内物质与内环境隔离的功能,以维持内环境的相对稳定和机体的正常生命活动。其功能的维持依赖于人肠黏膜上皮细胞、肠道内正常菌群、肠道内分泌物和肠相关免疫细胞之间的功能协调,而其功能的发挥又受体内许多信号分子的影响。短链脂肪酸（short-chain fatty acids,SCFAs）就是其中一种重要的信号分子。SCFAs是肠道菌群的主要代谢产物之一,是肠道菌群与宿主代谢相互作用的媒介。宿主体内的SCFAs主要来自肠道菌群对膳食纤维的酵解,越来越多的研究证实,SCFAs不仅可以被肠道菌群利用,还可调节肠黏膜屏障及多种组织器官的代谢。本文主要就SCFAs对肠黏膜屏障的影响进行综述。

     

Long-chain fatty acid transport in bacteria andyeast. Paradigms for defining the mechanism underlying this protein-mediated process

Protein-mediated transport of exogenous long-chain fatty acids across the membrane has been defined in a number of different systems. Central to understanding the mechanism underlying this process is the development of the appropriate experimental systems which can be manipulated using the tools of molecular genetics. Escherichia coli and Saccharomyces cerevisiae are ideally suited as model systems to study this process in that both [1] exhibit saturable long-chain fatty acid transport at low ligand concentration; [2] have specific membrane-bound and membrane-associated proteins that are components of the transport apparatus; and [3] can be easily manipulated using the tools of molecular genetics. In E. coli, this process requires the outer membrane-bound fatty acid transport protein FadL and the inner membrane associated fatty acyl CoA synthetase (FACS). FadL appears to represent a substrate specific channel for long-chain fatty acids while FACS activates these compounds to CoA thioesters thereby rendering this process unidirectional. This process requires both ATP generated from either substrate-level or oxidative phosphorylation and the proton electrochemical gradient across the inner membrane. In S. cerevisiae, the process of long-chain fatty acid transport requires at least the membrane-bound protein Fat1p. Exogenously supplied fatty acids are activated by the fatty acyl CoA synthetases Faa1p and Faa4p but unlike the case in E. coli, there is not a tight linkage between transport and activation. Studies evaluating the growth parameters in the presence of long-chain fatty acids and long-chain fatty acid transport profiles of a fat1 strain support the hypothesis that Fat1p is required for optimal levels of long-chain fatty acid transport.